Many survivors of stroke because of intracerebral hemorrhage (ICH) are at risk of ischemic vascular disease. Antithrombotic (antiplatelet or anticoagulant) treatments may lower the risk of ischemic events after ICH,… Click to show full abstract
Many survivors of stroke because of intracerebral hemorrhage (ICH) are at risk of ischemic vascular disease. Antithrombotic (antiplatelet or anticoagulant) treatments may lower the risk of ischemic events after ICH, but they may increase the risks of bleeding. To determine the overall effectiveness and safety of antithrombotic drugs for secondary prevention after ICH.1 ### Search Methods We searched the Cochrane Stroke Group Trials Register (March 24, 2017), the CENTRAL (Cochrane Central Register of Controlled Trials: the Cochrane Library 2017, Issue 3), Ovid Medline (from 1948 to March 2017), Ovid Embase (from …
               
Click one of the above tabs to view related content.